par de Azambuja, Evandro ;Dinh, Phuong ;Piccart-Gebhart, Martine
Référence Clinical advances in hematology & oncology, 5, 9, page (707-717)
Publication Publié, 2007-09
Référence Clinical advances in hematology & oncology, 5, 9, page (707-717)
Publication Publié, 2007-09
Article révisé par les pairs
Titre: |
|
Auteur: | de Azambuja, Evandro; Dinh, Phuong; Piccart-Gebhart, Martine |
Informations sur la publication: | Clinical advances in hematology & oncology, 5, 9, page (707-717) |
Statut de publication: | Publié, 2007-09 |
Sujet CREF: | Sciences bio-médicales et agricoles |
MeSH keywords: | Antibodies, Monoclonal -- adverse effects |
Antibodies, Monoclonal -- economics | |
Antibodies, Monoclonal -- therapeutic use | |
Antineoplastic Agents -- adverse effects | |
Antineoplastic Agents -- economics | |
Antineoplastic Agents -- therapeutic use | |
Breast Neoplasms -- drug therapy | |
Breast Neoplasms -- economics | |
Breast Neoplasms -- mortality | |
Chemotherapy, Adjuvant | |
Clinical Trials as Topic | |
Female | |
Heart Diseases -- chemically induced | |
Humans | |
Neoplasm Recurrence, Local -- drug therapy | |
Neoplasm Recurrence, Local -- economics | |
Neoplasm Recurrence, Local -- mortality | |
Protein Structure, Tertiary | |
Receptor, erbB-2 -- antagonists & inhibitors | |
Survival Rate | |
Note générale: | Journal Article |
Review | |
Langue: | Anglais |
Identificateurs: | urn:issn:1543-0790 |
info:pmid/17982412 |